CN106581633A - Lucid ganoderma oral liquid and preparation method thereof - Google Patents
Lucid ganoderma oral liquid and preparation method thereof Download PDFInfo
- Publication number
- CN106581633A CN106581633A CN201611070229.8A CN201611070229A CN106581633A CN 106581633 A CN106581633 A CN 106581633A CN 201611070229 A CN201611070229 A CN 201611070229A CN 106581633 A CN106581633 A CN 106581633A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- maca
- burdock
- ginseng
- stevioside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 28
- 241000222336 Ganoderma Species 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract description 19
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 19
- 229940013618 stevioside Drugs 0.000 claims abstract description 19
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000019202 steviosides Nutrition 0.000 claims abstract description 19
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 18
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 18
- 244000068988 Glycine max Species 0.000 claims abstract description 18
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 18
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 18
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 14
- 238000005516 engineering process Methods 0.000 claims abstract description 12
- 240000000759 Lepidium meyenii Species 0.000 claims description 16
- 240000008397 Ganoderma lucidum Species 0.000 claims description 15
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 241000208843 Arctium Species 0.000 claims 5
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 1
- 235000021286 stilbenes Nutrition 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 240000005528 Arctium lappa Species 0.000 abstract description 13
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 210000000987 immune system Anatomy 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000001093 anti-cancer Effects 0.000 abstract description 4
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 102000014150 Interferons Human genes 0.000 abstract description 2
- 108010050904 Interferons Proteins 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000000378 dietary effect Effects 0.000 abstract description 2
- 230000002124 endocrine Effects 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 229940079322 interferon Drugs 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 2
- 235000006533 astragalus Nutrition 0.000 abstract 2
- 230000035622 drinking Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000134128 Syncope Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940054288 iron and multivitamin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100001081 no carcinogenicity Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a lucid ganoderma oral liquid and a preparation method thereof. The lucid ganoderma oral liquid is prepared from: lucid ganoderma, ginseng, cordyceps militaris, DHA powder, stevioside, MACA, soybean peptide, burdock and astragalus membranaceus. The lucid ganoderma oral liquid has the following advantages: 1) the oral liquid is produced through superfine grinding technology, so that all active components in the lucid ganoderma, ginseng, cordyceps militaris, MACA, burdock and astragalus membranaceus are completely maintained, and a bitter taste of the lucid ganoderma is eliminated, dietary value of the medicine components are fully achieved, and the oral liquid has scientific and reasonable formula, is balanced and complemented in property and flavor and achieves addition of effects; 2) the oral liquid can improve immunity and endocrine regulation capability, and can accelerate body metabolism and induce generation of interferon, thereby achieving anti-cancer effect, and meanwhile, the oral liquid can treat tumors and is safe and toxic-free, is suitable for people for drinking for a long time, especially, for diabetic patients; and 3) by means of the oral liquid, body physique is improved and disease resistant capability is improved, removal of virus by immune system is promoted and recovery of patients is improved.
Description
Technical field
The present invention relates to field of traditional Chinese medicine technology, more particularly to a kind of Ganoderma lucidum oral liquid and its preparation technology.
Background technology
Glossy ganoderma has strengthens the body resistance to consolidate the constitution, and strengthens immunologic function, improves the great function of Abwehrkraft des Koepers.It is different from general medicine
Thing plays therapeutic action to certain disease, also only the deficiency of nutrient in a certain respect is carried out different from general nutritional health food
Supplement and strengthen, but bidirectional modulation function of human body balance on the whole, internal body vigor is transferred, adjust human metabolism
Function, improves autoimmunity ability, promotes whole internal organ or organ function normalization.But glossy ganoderma in the market is oral
Liquid, effect is single, and anticancer, anti-cancer, the tumour that suppresses, liver detoxification, strong lung lipid-loweringing, regulation immunity curative effect be not obvious.
The content of the invention
The technical problem to be solved is：In order to solve above the problems of the prior art, the invention provides
One kind is prepared simply, a kind of Ganoderma lucidum oral liquid evident in efficacy and its preparation technology.
The present invention is to solve the problems, such as that adopted technical scheme set forth above is：
A kind of Ganoderma lucidum oral liquid, is made up of the bulk drug of following weight portion：
Glossy ganoderma 25-35kg；Ginseng 7-13kg；Cordyceps militaris 3-8kg；DHA powder 2-5kg；Stevioside 0.2-0.5kg；Maca 3-6kg；
Soybean Peptide 5-10kg；Burdock 5-10kg；Radix Astragali 5-10kg.
Preferably, the Ganoderma lucidum oral liquid, is made up of the bulk drug of following weight portion：
Glossy ganoderma 28-30kg；Ginseng 9-11kg；Cordyceps militaris 5-7kg；DHA powder 3-5kg；Stevioside 0.3-0.5kg；Maca 4-5kg；
Soybean Peptide 8-10kg；Burdock 8-10kg；Radix Astragali 7-10kg.
In one embodiment of the invention, the Ganoderma lucidum oral liquid, is made up of the bulk drug of following weight portion：
Glossy ganoderma 30kg；Ginseng 10kg；Cordyceps militaris 6kg；DHA powder 5kg；Stevioside 0.3kg；Maca 6kg；Soybean Peptide 8kg；Burdock
8kg；Radix Astragali 6kg.
The pharmaceutical characteristic of each bulk drug that the present invention is adopted is as follows：
Glossy ganoderma：Glossy ganoderma is sweet, gas is flat, has promotion human immune system to kill tumour cell, and effective function of tumor inhibition, immunity is adjusted
Section is acted on, strengthen the body resistance to consolidate the constitution, strengthening by means of tonics, effect of promoting longevity, have stomach living, nourishing the liver detoxication concurrently, sedation and analgesia is acted on, hence it is evident that
Reduce blood cholesterol and serum triglyceride level, the occurrence and development of atherosclerosis, step-down and reinforcement heart contraction
The effect of power, has phlegm-dispelling functions to respiratory system.
Ginseng：Ginseng is the dry root of Araliaceae ginseng.Its sweet and slightly bitter taste, it is warm in nature, enter spleen, lung, the heart channel of Hang-Shaoyin, with big
Tonifying primordial Qi, reinforce the spleen to benefit the lung, promote the production of body fluid to quench thirst, increasing intelligence of calming the nerves the effects such as, it is adaptable to Spleen-Qi Deficiency, Lung Qi deficiency and various qi-asthenia syncopes are de- etc.
Disease.History tree is affirmed fully invariably, and ginseng plays the role of qi-restoratives anti-aging and promotes longevity.
Cordyceps militaris：Cordyceps militaris be it is unique have can tonifying lung it is cloudy, and can tonifying kidney and strengthening yang, adjust effect of equilibrium between yin and yang.
Cordyceps militaris enters lung, kidney two warp, there is regulation function of immune system, antitumor, antifatigue, anti-ageing several functions of waiting for a long time.
DHA powder：DHA is the important feature material for constituting brain and retina, is to maintain fat necessary to cerebral function
Acid.
Stevioside：Stevioside is the new type natural sweetener extracted in a kind of herbaceous wild plants STEVIA REBAUDIANA from composite family, is
The third has the natural sweetener that Development volue and health are praised highly outside sugarcane, beet sugar, and " third place in the world is described as in the world
Sugar source ".The characteristics of it has safe, high sugariness, low calorie.Stevioside originates in the ground such as South America Paraguay, Brazil, local
The edible existing centuries history of resident, finds no so far any murder by poisoning, and the domestic and international pharmacological evaluations of Jing are proved, stevioside is non-
Carcinogenicity material, no side effectses, edible safety.Its sugariness is 200 to 400 times of sucrose, and heat is only the 1/ of sucrose
300, can be applicable to low-calorie diet, beverage and medicine.Stevioside hardly participates in metabolism, is only capable of feeling that its is sweet after taking
Taste, it is most of to be discharged from urine and excrement with original shape.Long-term consumption stevioside will not make one to get fat, and have hypoglycemic, preventing decayed tooth
Tooth, stomach invigorating, the function of relieving fatigue, and to the edible for patients such as body building and weight reducing and diabetes, heart disease, hypertension, artery sclerosis
There is auxiliary curative effect.
Maca：Maca improves fertility, improves the effects such as sexual function, anticancer, anti-leukocythemia, treatment climacteric metancholia
Become current study hotspot and obtain universal checking.Particularly in recent years, with the continuous development of science, environment
Seriously polluted, rhythm of life is fast, energy overdraw, that operating pressure is big, bad life habits, physical exercise are reduced increasingly etc. is various
Factor causes modern society's sub-health state crowd's generally existing.The nutrient content of maca general equilibrium and exclusive vigor thing
Matter, can effectively firm immune system, improve sub-health state, have been obtained for being widely recognized as many people.
Soybean Peptide：Soybean Peptide is that soybean protein isolate passes through enzymolysis, and it not only has soybean protein isolate itself
Nutritive peculiarity, while Soybean Peptide or a kind of low molecular weight protein with peculiar physiological function.Substantial amounts of result of study table
Bright, after body intake protein, it, with the absorption of free amino acid form, is more in the form of low molecular peptide to be not fully
Absorbed；In addition, Soybean Peptide can be absorbed by the body rapidly, its absorption rate than same composition protein and amino acid more
Hurry up, and Soybean Peptide also has and improves the health care of sleep, reducing blood lipid, increase immunity of organisms, strengthen muscle, various physiology such as fatigue-relieving
Function.
Burdock：For composite family 2-3 lifes, the draft taproot class plant of medicine-food two-purpose.Also known as burdock father-in-law's dish, pizzle dish, Fructus Arctii,
Great Burdock Achene etc..Radix bardanae is nutritious, rich in the mineral matters such as synanthrin, cellulose, protein, calcium, phosphorus, iron and multivitamin,
And with very strong health care.Jing often to eat radix bardanaes stimulate circulation, remove stomach rubbish, prevent human body mistake
Presenility, moist skin, prevent apoplexy and hypertension, detoxicating intestine, reduce cholesterol and blood sugar, and being adapted to diabetic
Long-term consumption（Because containing synanthrin in radix bardanae）, rheumatoid is antimycotic to have certain curative effect, also has very well to cancer and uremia
Prevention and inhibitory action, therefore be described as the optimal hematocathartic of the Nature.
The Radix Astragali：It is warm in nature for conventional Chinese medicine, it is sweet, with invigorating qi for strengthening superficies, diuretic and maintain drug, apocenosis, expelling pus and promoting granulation function.
Present invention also offers a kind of preparation technology of Ganoderma lucidum oral liquid, comprises the following steps：
Weigh glossy ganoderma 25-35kg；Ginseng 7-13kg；Cordyceps militaris 3-8kg；DHA powder 2-5kg；Stevioside 0.2-0.5kg；Maca 3-
6kg；Soybean Peptide 5-10kg；Burdock 5-10kg and Radix Astragali 5-10kg, adopts micronizer to be ground into granularity for 100-300 purposes
Particle, breaking-wall cell is reached, add the water of 5 times of weight, circulation to extract in above-mentioned raw materials 4 hours, merge extract, mistake
Filter, concentration, obtain concentrate, finally by mixed liquor embedding in the sterile glass vials of 30ml.
The beneficial effects of the present invention is：1st, the present invention adopts superfine communication technique, maintain both completely losslessly glossy ganoderma,
All functional components of ginseng, Cordyceps militaris, maca, burdock and the Radix Astragali, overcome the bitter taste of glossy ganoderma again, take full advantage of many persons'
Dietary significance, proportioning is scientific and reasonable, reaches the effect of nature and flavor balance is complementary, effect is superimposed.2nd, the present invention is without any auxiliary material
And food additives, particle exquisiteness, uniform color, easily dispersion, easily reconstitute.3rd, the present invention can enhance immunity and endocrine tune
Energy-conservation power, can accelerate the metabolism of body, and induction produces interferon and plays antitumaous effect, while can also treat tumour, pacify
Atoxic, suitable masses drink for a long time, and especially diabetic also can take.4th, many medicines are through liver detoxification, medication
Excessive excessively miscellaneous increase burden of liver, it is unfavorable to hepatopathy, but the present invention specially consider in compatibility patient's liver toxin expelling because
Procatarxis this, will not to patient increase side effect, on the contrary can by take the present invention improve physique, strengthen resistance against diseases, promote
Immune system removes virus, promotes disease recovery.
Specific embodiment
In order that those skilled in the art are better understood from technical scheme, with reference to specific embodiment to this
Invention is further detailed.
Embodiment 1：
A kind of preparation technology of the Ganoderma lucidum oral liquid described in this specific embodiment, comprises the following steps：
Weigh glossy ganoderma 28kg；Ginseng 9kg；Cordyceps militaris 5kg；DHA powder 3kg；Stevioside 0.3kg；Maca 5kg；Soybean Peptide 7kg；Ox
Burdock 7kg and Radix Astragali 7kg, adopt micronizer to be ground into granularity for 100-300 mesh particle, breaking-wall cell is reached, to above-mentioned
Add the water of 5 times of weight, circulation to extract in raw material 4 hours, merge extract, filtration, concentration obtain concentrate, finally will
Mixed liquor embedding is in the sterile glass vials of 30ml.
Usage and dosage：This product is oral liquid, orally.It is daily 1-3 time, each 30ml.
Embodiment 2：
A kind of preparation technology of the Ganoderma lucidum oral liquid described in this specific embodiment, comprises the following steps：
Weigh glossy ganoderma 32kg；Ginseng 11kg；Cordyceps militaris 7kg；DHA powder 4kg；Stevioside 0.4kg；Maca 5kg；Soybean Peptide 8kg；Ox
Burdock 8kg and Radix Astragali 8kg, adopt micronizer to be ground into granularity for 100-300 mesh particle, breaking-wall cell is reached, to above-mentioned
Add the water of 5 times of weight, circulation to extract in raw material 4 hours, merge extract, filtration, concentration obtain concentrate, finally will
Mixed liquor embedding is in the sterile glass vials of 30ml.
Usage and dosage：This product is oral liquid, orally.It is daily 1-3 time, each 30ml.
Embodiment 3：
A kind of preparation technology of the Ganoderma lucidum oral liquid described in this specific embodiment, comprises the following steps：
Weigh glossy ganoderma 30kg；Ginseng 9kg；Cordyceps militaris 6kg；DHA powder 3kg；Stevioside 0.3kg；Maca 4kg；Soybean Peptide 9kg；Ox
Burdock 9kg and Radix Astragali 7kg, adopt micronizer to be ground into granularity for 100-300 mesh particle, breaking-wall cell is reached, to above-mentioned
Add the water of 5 times of weight, circulation to extract in raw material 4 hours, merge extract, filtration, concentration obtain concentrate, finally will
Mixed liquor embedding is in the sterile glass vials of 30ml.
Usage and dosage：This product is oral liquid, orally.It is daily 1-3 time, 30ml.
The specific embodiment of the present invention is not construed as limiting the invention, every analog structure and change using the present invention
Change, within the scope of the present invention.
Claims (5)
1. a kind of Ganoderma lucidum oral liquid thing, is made up of the bulk drug of following weight portion：Glossy ganoderma 25-35kg；Ginseng 7-13kg；Cordyceps militaris
3-8kg；DHA powder 2-5kg；Stevioside 0.2-0.5kg；Maca 3-6kg；Soybean Peptide 5-10kg；Burdock 5-10kg；Radix Astragali 5-
10kg。
2. a kind of Ganoderma lucidum oral liquid thing as claimed in claim 1, is made up of the bulk drug of following weight portion：Glossy ganoderma 28-30kg；
Ginseng 9-11kg；Cordyceps militaris 5-7kg；DHA powder 3-5kg；Stevioside 0.3-0.5kg；Maca 4-5kg；Soybean Peptide 8-10kg；Burdock
8-10kg；Radix Astragali 7-10kg.
3. a kind of Ganoderma lucidum oral liquid thing as claimed in claim 1, is made up of the bulk drug of following weight portion：Glossy ganoderma 30kg；People
Ginseng 10kg；Cordyceps militaris 6kg；DHA powder 5kg；Stevioside 0.3kg；Maca 6kg；Soybean Peptide 8kg；Burdock 8kg；Radix Astragali 6kg.
4. a kind of preparation technology of Ganoderma lucidum oral liquid thing, comprises the following steps：
Weigh glossy ganoderma 25-35kg；Ginseng 7-13kg；Cordyceps militaris 3-8kg；DHA powder 2-5kg；Stevioside 0.2-0.5kg；Maca 3-
6kg；Soybean Peptide 5-10kg；Burdock 5-10kg and Radix Astragali 5-10kg, adopts micronizer to be ground into granularity for 100-300 purposes
Particle, reaches breaking-wall cell, adds the water of 5 times of weight, circulation to extract in above-mentioned raw materials 4 hours, merges extract, mistake
Filter, concentration, obtain concentrate, finally by mixed liquor embedding in the sterile glass vials of 30ml.
5. a kind of preparation technology of Ganoderma lucidum oral liquid thing as claimed in claim 4, each raw material survival dose is as follows in parts by weight：
Glossy ganoderma 30kg；Ginseng 10kg；Cordyceps militaris 6kg；DHA powder 5kg；Stevioside 0.3kg；Maca 6kg；Soybean Peptide 8kg；Burdock 8kg；It is yellow
Stilbene 6kg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611070229.8A CN106581633A (en) | 2016-11-29 | 2016-11-29 | Lucid ganoderma oral liquid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611070229.8A CN106581633A (en) | 2016-11-29 | 2016-11-29 | Lucid ganoderma oral liquid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106581633A true CN106581633A (en) | 2017-04-26 |
Family
ID=58595479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611070229.8A Pending CN106581633A (en) | 2016-11-29 | 2016-11-29 | Lucid ganoderma oral liquid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106581633A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107156591A (en) * | 2017-07-14 | 2017-09-15 | 凌海航天灵芝生物科技有限公司 | A kind of glossy ganoderma health solid beverage |
| CN110122850A (en) * | 2019-06-10 | 2019-08-16 | 山东瑞芝生物科技股份有限公司 | A kind of production technology and formula of Sugarless glossy ganoderma water |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1142952A (en) * | 1994-12-17 | 1997-02-19 | 李高寅 | Glossy ganoderma oral liquor and its preparing method |
| CN1185908A (en) * | 1996-12-27 | 1998-07-01 | 李江 | Functional cordyceps sinensis milk, products made from cordyceps sinensis milk and preparation thereof |
| CN104256754A (en) * | 2014-02-14 | 2015-01-07 | 亳州市益寿轩药膳食品有限公司 | Maca healthcare solid beverage formula for women and preparing method thereof |
| CN104855972A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full-nutrient formula food for menopause delaying and regulation of females |
-
2016
- 2016-11-29 CN CN201611070229.8A patent/CN106581633A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1142952A (en) * | 1994-12-17 | 1997-02-19 | 李高寅 | Glossy ganoderma oral liquor and its preparing method |
| CN1185908A (en) * | 1996-12-27 | 1998-07-01 | 李江 | Functional cordyceps sinensis milk, products made from cordyceps sinensis milk and preparation thereof |
| CN104256754A (en) * | 2014-02-14 | 2015-01-07 | 亳州市益寿轩药膳食品有限公司 | Maca healthcare solid beverage formula for women and preparing method thereof |
| CN104855972A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full-nutrient formula food for menopause delaying and regulation of females |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107156591A (en) * | 2017-07-14 | 2017-09-15 | 凌海航天灵芝生物科技有限公司 | A kind of glossy ganoderma health solid beverage |
| CN110122850A (en) * | 2019-06-10 | 2019-08-16 | 山东瑞芝生物科技股份有限公司 | A kind of production technology and formula of Sugarless glossy ganoderma water |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101496578B (en) | Special diet and foodstuffs formula containing small peptide for hepatopath | |
| CN101041023A (en) | Chinese traditional compound good for spleen and for improving appetite and food-digesting and the preparing method | |
| CN101168710B (en) | Eucommia bark wine and preparation method thereof | |
| CN103027138A (en) | Tea for enlivening spleens and production method of tea | |
| CN101053621B (en) | Traditional Chinese medicinal composition for treating obesity and its preparation method | |
| CN104172186A (en) | Convenient food capable of conditioning liver tumor | |
| CN102755346A (en) | Compound polysaccharide formula of edible fungus as well as preparation method and application thereof | |
| CN112546167A (en) | Traditional Chinese medicine composition with spleen invigorating and dampness removing functions and preparation method and application thereof | |
| CN101711840B (en) | Medicine-food dual-purpose composition suitable for cancerous patients and preparation method thereof | |
| CN103238889A (en) | Anti-fatigue apple vinegar health beverage and preparation method thereof | |
| CN106581633A (en) | Lucid ganoderma oral liquid and preparation method thereof | |
| CN106421374A (en) | Traditional Chinese medicine composition for treating diabetes and application method thereof | |
| CN115645491A (en) | Traditional Chinese medicine composition for tonifying spleen and lung and preparation method thereof | |
| CN104187667A (en) | Convenient food for treating stomach cancer | |
| CN100364450C (en) | Alcohol-dissolving liver-protecting healthy food | |
| CN103689558A (en) | Health-preserving health food formula having multiple functions and preparation method thereof | |
| CN113785948A (en) | Solid beverage capable of benefiting qi, promoting production of body fluid and relaxing bowel and preparation method thereof | |
| CN113842452A (en) | Medicine composition for treating diabetes and preparation method thereof | |
| CN112807415A (en) | Spleen and stomach warming and tonifying middle-jiao tea and preparation method thereof | |
| CN105147944B (en) | A kind of Chinese medicine composition, its preparation and its preparation method and application | |
| CN104187662A (en) | Convenient food for conditioning ovarian cancer | |
| CN104187725A (en) | Convenient food for conditioning colorectal neoplasms | |
| CN104738744A (en) | Blood pressure and blood lipid reduction beverage and preparation method thereof | |
| CN105087296A (en) | Eucommia wine and preparation method thereof | |
| CN103689560A (en) | Health-preserving health food formula beneficial for prolonging life span and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170426 |
|
| RJ01 | Rejection of invention patent application after publication |